US pharma major Pfizer Inc has decided to shut down its manufacturing units in Irungattukottai, Chennai and Aurangabad, Maharashtra, which came to it through an acquisition of injectables manufacturer Hospira in 2015.
Over 1,700 employees working in these two factories are expected to be impacted by the decision. While the company is shutting down the two facilities, plans are afoot to expand the Vizag manufacturing facility, which also came as part of the acquisition.
Pfizer said that it conducted a thorough evaluation of the Irungattukottai and Aurangabad sites and concluded that due to a significant fall in product demand, manufacturing at these